# The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal

> **NCT03451942** · PHASE2 · UNKNOWN · sponsor: **Henan Cancer Hospital** · enrollment: 112 (estimated)

## Conditions studied

- Adenocarcinoma of the Stomach / Gastroesophageal

## Interventions

- **DRUG:** FLOT regimen chemotherapy
- **PROCEDURE:** D2 gastric and imaging metastases resection

## Key facts

- **NCT ID:** NCT03451942
- **Lead sponsor:** Henan Cancer Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-05
- **Primary completion:** 2019-09
- **Final completion:** 2021-03
- **Target enrollment:** 112 (ESTIMATED)
- **Last updated:** 2018-03-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03451942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03451942, "The FLOT Regimen Conversion Therapy of Adenocarcinoma of the Stomach / Gastroesophageal". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03451942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*